Stake Purchase • Life Science

KKR Invests In Nordic Bioscience

On March 3, 2021, private equity firm KKR invested in life science company Nordic Bioscience

Investment Context
  • This is KKR’s 15th transaction in the Life Science sector.
  • This is KKR’s 2nd transaction in Denmark.

Explore All 282 Stake Purchase Life Science Deals - Search the Database Free


Investment Summary

Date March 3, 2021
Target Nordic Bioscience
Sector Life Science
Investor(s) KKR
Deal Type Stake Purchase
Advisor(s) Nordic M&A (Financial)

Target Company

Nordic Bioscience

Herlev, Denmark
Nordic Bioscience is an expert in the extracellular matrix (ECM) with experience in biomarker development, clinical and pre-clinical research. Fragments from the reactive stroma and ECM have been identified by the research team at Nordic Bioscience and corresponding quantification assays have been developed in parallel. Nordic Bioscience was founded in 1991 and is based in Herlev, Denmark.
Explore More Deals

Browse All 215,158 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

KKR

New York, New York, United States

Investor Investor Investor Investor Investor


Category Private Equity Firm
Founded 1976
PE ASSETS 267.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION
KKR's office in Menlo Park, California.
KKR's office in Menlo Park, California.

KKR is a global investment firm founded by Jerome Kohlberg, Henry Kravis, and George Roberts. The Firm is separated into several business segments including private markets, public markets, capital markets, and other principal activities. KKR's private equity practice invests in management buyouts, take privates, corporate divestitures, industry consolidations, and partnerships with family-owned companies. KKR will invest in a broad range of industries and companies and will consider businesses throughout North America, Europe, Asia, and Australia/New Zealand. Sectors of interest include chemicals, consumer products, energy and natural resources, financial services, healthcare, industrial, media/communications, retail, and technology. In addition to its traditional principal investment activity business, KKR also invests in infrastructure assets. KKR was formed in 1976 and is based in New York, New York.


Deal Context for Investor #
Overall 375 of 503
Sector: Life Science 15 of 21
Type: Stake Purchase 53 of 66
Country: Denmark 2 of 2
Year: 2021 7 of 52
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-03 Caruna

Caruna, Finland

Caruna is a regulated electricity distribution utility serving southern, south-western, western and northern Finland and is the country’s largest electricity distribution network. Caruna is based in Caruna, Finland.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2021-03-04 ISC

Carlsbad, California, United States

ISC is a multi-line insurance distributor that builds end-to-end insurance products utilizing advanced artificial intelligence (AI) engineering and data analytics. ISC has built an end-to-end insurance platform by connecting a broad network of insurance markets and distribution channels with proprietary data analytics capabilities. ISC was founded in 2017 and is based in Carlsbad, California.

Buy -

Explore Related M&A Activity